Retro is a mission-first company committed to extending healthy human lifespan by 10 years. We seek world-class scientists who fit our 5-dimensional culture: 1. Adventurous - More pirate than navy. We dive in and engineer around obstacles. 2. Direct and clear - Shortest path to close the loop. High signal to noise. Zero politics. 3. High-Performers - We are players not watchers. Driven. Mad skills without hubris. Best person for the role. 4. T-Shaped - Curiosity has driven us to learn broadly and, in at least one domain, deeply. 5. Optimistic and Mission-focused - We believe we can fundamentally improve the human condition. If our mission and culture resonate with you, reach out. It’s time to build! https://retro.bio/careers/ #NowHiring #Aging #BioTech
Retro Biosciences
Biotechnology Research
Aspiration to add 10 years to healthy human lifespan. Cellular reprogramming, autophagy, & plasma-inspired therapeutics.
About us
Aspiring to add 10 years to healthy human lifespan, starting with cellular reprogramming, autophagy, & plasma-inspired therapeutics
- Website
-
http://retro.bio/
External link for Retro Biosciences
- Industry
- Biotechnology Research
- Company size
- 11-50 employees
- Headquarters
- San Francisco
- Type
- Privately Held
Locations
-
Primary
Get directions
San Francisco, US
Employees at Retro Biosciences
Updates
-
We're excited to partner with Multiply Labs! Their cutting edge technology will bolster our efforts to add 10 years to healthy human lifespan. Read more in the post below which includes the press release link.
Today, we announced an $85 million commercial partnership with Retro Biosciences! Our robotic system will enable Retro to manufacture cell therapies at a cost-efficient scale, expediting their transition from process development to clinical trials and commercialization. Retro, supported by a recent investment by Sam Altman (CEO of OpenAI), is a biotechnology company driven by a mission to extend healthy human lifespan by a decade, targeting the cellular drivers of aging. This partnership underscores the versatility of our robotic system for automating the manufacturing processes for both autologous and allogeneic therapies. As "Joe Betts-LaCroix" CEO of Retro, said, “The accelerating rate of change in cell therapies motivated us to look for a manufacturing platform with flexibility at its core. The modular structure of the Multiply Labs robots will help enable Retro to bring its unique cell therapies to patients." Read more on our partnership here: https://bit.ly/3UCCKJT #robotics #automation #celltherapy #longevity #biotech
-
Our thanks to Hilary Brueck at the Business Insider for profiling Retro - the why and how we are "breaking all the rules of early-stage biotech" to achieve our mission of adding 10 years of healthy lifespan. https://lnkd.in/gHJJs-VJ
-
Next month, our CEO "Joe Betts-LaCroix" will share insights on longevity and aging science alongside Kristen Fortney and Matt Kaeberlein at The Alliance for Longevity Initiatives’s inaugural D.C. Fly-In event uniting scientists, policymakers, and longevity industry leaders. Learn more at a4li.org
Join us for The Alliance for Longevity Initiatives (A4LI)'s inaugural D.C. Fly-In event on March 20-21, 2024! This groundbreaking gathering will unite leading scientists and policymakers committed to advancing legislative and policy initiatives that promote healthy human lifespan. By attending, you'll have the opportunity to: - Engage in critical conversations with industry experts and policymakers. - Contribute to shaping the future of longevity biotechnology. - Network with like-minded individuals and key stakeholders. - Advocate for policies that support healthy aging and combat age-related diseases. Don't miss this chance to join the forefront of longevity advocacy and policy development. Secure your spot today and help drive positive change for the future of human health and longevity. Spots are limited, so register today with this link: https://lnkd.in/esxnYAWV We look forward to welcoming you all on Capitol Hill this March!
-
-
Thanks to Omri Amirav-Drory and Eric Ward at NFX for featuring Retro and insights from our CEO Joe Betts-Lacroix in this inspiring documentary showcasing key efforts to shape the future of longevity science.
We're at the beginning of a landmark moment for Longevity. The companies built in the next 10 years will power a radical transition from sickcare to true healthcare. Today we're releasing a new documentary w/ Omri Amirav-Drory & top scientists and founders in our network about the future of Longevity: https://lnkd.in/gdsQiRa4
The Future of Longevity: The Battle Against Human Aging (NFX Original)
https://www.youtube.com/
-
Thanks to Ashlee Vance at Bloomberg Businessweek for the in-depth look at how we built Retro, our intensely challenging and ambitious research tracks, and the longevity science we’re pioneering to achieve our mission — extending healthy human lifespan. Read the article: https://lnkd.in/dBHw9AHT
The Most Secretive Longevity Lab Finally Opens Its Doors
bloomberg.com
-
At next month’s inaugural Biomarkers of Aging Consortium symposium, our CEO Joe Betts-Lacroix will join the “Industry Panel” for a conversation with longevity industry leaders Alex Zhavoronkov, Kristen Fortney, and Peter Fedichev. Learn more about the event at the Buck Institute for Research on Aging: https://lnkd.in/g-9zsrDU #BoAS2023
-
-
Thanks to moderator Abby Levy and guests Melanie Goldey, Robert Hariri, MD, PhD, and Kristy N. Berry for an insightful “30 Going on 13” panel at #HLTH2023 last week. Our co-founder and CEO Joe Betts-Lacroix shared his perspectives on the future of longevity science and its impact on healthcare.
-
-
Thanks to Geoffrey Carr for highlighting our mission to extend healthy human lifespan and our autophagy program in The Economist’s "In search of forever” report. Read the full feature: https://lnkd.in/gbw5yhEb
Slowing human ageing is now the subject of serious research
economist.com